NR 566 (ADVANCED PHARMACOLOGY FOR CARE OF
FAMILY) COMPLETE QUIZZES, MIDTERMS & FINAL EXAM
BANK
550+ (Updated 2026) Complete Exam Pack | A+ Graded Questions & Verified Answers
Document Overview
This comprehensive examination package contains 551 expertly curated questions across 4 critical modules : NR 566
MIDTERM EXAM, NR566 MIDTERM EXAM REVIEW, NR 566 Final EXAM REVIEW, NR 566 FINAL EXAM. Each question is
accompanied by verified correct answers and detailed rationales designed to enhance understanding and retention. This 2026-updated
resource provides complete coverage of essential concepts, clinical applications, and evidence-based practices. Perfect for certification
preparation, academic review, and professional development.
Table of Contents
NR 566 MIDTERM EXAM .............................................................................................. Q1-241
NR566 MIDTERM EXAM REVIEW ................................................................................... Q242-328
NR 566 Final EXAM REVIEW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Q329-435
NR 566 FINAL EXAM .............................................................................................. Q436-551
,NR 566 MIDTERM EXAM 241 Questions
Question 1 NR 566 MIDTERM EXAM
Which non-amphetamines are FDA approved for weight loss that have lower abuse risk?
CORRECT ANSWER
Phentermine and Diethylpropion
Rationale: Phentermine and Diethylpropion are FDA-approved for weight loss and considered to have a lower abuse risk because they are anorectic
agents that are chemically distinct from amphetamines, which are a class of highly addictive stimulants. This chemical distinction, combined with their
FDA approval and lower potency compared to amphetamines, contributes to their lower abuse potential and makes them suitable alternatives for
weight loss treatment.
Question 2 NR 566 MIDTERM EXAM
How does Phentermine and Diethylpropion promote weight loss?
CORRECT ANSWER
-Promote weight loss by decreasing appetite
-They are central nervous system (CNS) stimulants that suppress appetite by increasing the availability of norepinephrine at receptors in
the brain
Rationale: Phentermine and Diethylpropion promote weight loss by influencing the brain's neurotransmitter system, specifically increasing
norepinephrine availability, which in turn suppresses appetite. This mechanism is a direct result of their classification as central nervous system (CNS)
stimulants, allowing them to effectively reduce hunger and support weight loss.
Question 3 NR 566 MIDTERM EXAM
What is the maximum recommended duration of use for non-amphetamines?
CORRECT ANSWER
3 months or less
Rationale: The key concept underlying this recommendation is that non-amphetamines, like amphetamines, can lead to physical dependence and
withdrawal symptoms, making prolonged use potentially hazardous. By limiting the duration of use to 3 months or less, the risk of dependence and
adverse effects from non-amphetamines can be minimized, aligning with the goal of promoting safe and responsible use.
Question 4 NR 566 MIDTERM EXAM
What drug schedule are Phentermine and Diethylpropion under?
CORRECT ANSWER
Schedule IV
Rationale: Phentermine and Diethylpropion are classified as Schedule IV drugs due to their potential for abuse and dependence, but their therapeutic
benefits in treating obesity outweigh the risks, allowing them to be prescribed for medical use with certain restrictions. This classification distinguishes
them from Schedule III drugs, which have a higher abuse potential, and Schedule V drugs, which have the lowest potential for abuse and dependence.
,Question 5 NR 566 MIDTERM EXAM
What labs should be monitored with Phentermine and Diethylpropion? What condition should we screen for?
CORRECT ANSWER
-baseline CMP (watch electrolytes and creatinine)
-screen for depression
Rationale: Phentermine and Diethylpropion are both sympathomimetic amines, a class of medications that can cause electrolyte imbalances and renal
impairment as side effects, necessitating the monitoring of electrolytes and creatinine levels. Additionally, these medications can have a stimulant
effect, which increases the risk of developing depression, making it essential to screen for this condition.
Question 6 NR 566 MIDTERM EXAM
Phentermine adverse effects
CORRECT ANSWER
-increase HR and BP
-dry mouth and constipation
Rationale: Phentermine is a central nervous system stimulant that works by increasing the levels of certain neurotransmitters, which can cause
increased heart rate (HR) and blood pressure (BP). The stimulant and appetite-suppressing effects of phentermine can also lead to dry mouth and
constipation as a result of decreased saliva production and reduced gut motility, respectively.
Question 7 NR 566 MIDTERM EXAM
What is role of topiramate in weight loss?
CORRECT ANSWER
Increases satiety
Rationale: Topiramate's role in weight loss is primarily attributed to its ability to increase feelings of fullness and satisfaction, thereby reducing hunger
and calorie intake, which in turn leads to weight loss. This effect is thought to be due to topiramate's action on certain neurotransmitters in the brain
that regulate appetite and food cravings, ultimately resulting in increased satiety.
Question 8 NR 566 MIDTERM EXAM
What are some Phentermine/topiramate contraindications for use?
CORRECT ANSWER
not approved in children and contraindicated with severe hepatic impairment
Rationale: This correct answer is due to the fact that Phentermine/topiramate is a controlled-release oral capsule that is not suitable for pediatric use,
and pediatric safety and efficacy have not been established. Additionally, topiramate, one of the components, is primarily metabolized by the liver,
making it contraindicated in individuals with severe hepatic impairment as they may not be able to effectively break down the medication.
, Question 9 NR 566 MIDTERM EXAM
How should we educate patient to take Phentermine/topiramate to avoid insomnia?
CORRECT ANSWER
given before 1600
Rationale: Phentermine/topiramate is a medication that combines the stimulant phentermine with the anticonvulsant topiramate, which can increase
alertness and wakefulness, increasing the risk of insomnia when taken before bed. Therefore, educating patients to take this medication in the
morning, given before 1600 hours (4 pm), helps to minimize its stimulating effects and reduce the likelihood of insomnia.
Question 10 NR 566 MIDTERM EXAM
What are some high-risk patient conditions that we should use Phentermine/topiramate with caution?
CORRECT ANSWER
hx drug abuse, glaucoma, pregnant, HTN, hyperthyroidism
Rationale: Phentermine/topiramate is a weight loss medication that affects the central nervous system, which can interact with conditions such as
glaucoma, as increased intraocular pressure could worsen glaucoma, and may exacerbate conditions like hypertension and hyperthyroidism due to its
stimulant properties. The medication's teratogenic effects also necessitate caution in pregnant individuals, while its potential for abuse and interaction
with other substances requires careful consideration in individuals with a history of substance abuse.
Question 11 NR 566 MIDTERM EXAM
Phentermine/topiramate adverse effects
CORRECT ANSWER
insomnia, nervousness, anxiety, depression, blurred vision
Rationale: Phentermine/topiramate is a medication combination used for weight loss, and its adverse effects are often related to its impact on the
central nervous system. The listed symptoms, such as insomnia, nervousness, anxiety, depression, and blurred vision, are plausible consequences of
the medication's effects on the brain, particularly given topiramate's known side effects of mood changes and visual disturbances.
Question 12 NR 566 MIDTERM EXAM
Which of the following would be a contraindication to prescribing phentermine/topiramate? Select all that apply.
CORRECT ANSWER
A) Glaucoma
B) Hypothyroidism
C) Hypertension
D) Hyperthyroidism
E) Vitamin D Deficiency
F) A, B, E
ANSWER: A,C,D
Rationale: Phentermine/topiramate is a combination medication used for weight loss, but it can increase eye pressure, worsen glaucoma, and interact
with thyroid conditions, making glaucoma, hypertension, and hyperthyroidism contraindications. The medication can also exacerbate the eye pressure
issue associated with glaucoma and the potential cardiovascular effects may be a concern for individuals with hypertension, and its effects on the
thyroid gland can be an issue for those with hyperthyroidism.
FAMILY) COMPLETE QUIZZES, MIDTERMS & FINAL EXAM
BANK
550+ (Updated 2026) Complete Exam Pack | A+ Graded Questions & Verified Answers
Document Overview
This comprehensive examination package contains 551 expertly curated questions across 4 critical modules : NR 566
MIDTERM EXAM, NR566 MIDTERM EXAM REVIEW, NR 566 Final EXAM REVIEW, NR 566 FINAL EXAM. Each question is
accompanied by verified correct answers and detailed rationales designed to enhance understanding and retention. This 2026-updated
resource provides complete coverage of essential concepts, clinical applications, and evidence-based practices. Perfect for certification
preparation, academic review, and professional development.
Table of Contents
NR 566 MIDTERM EXAM .............................................................................................. Q1-241
NR566 MIDTERM EXAM REVIEW ................................................................................... Q242-328
NR 566 Final EXAM REVIEW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Q329-435
NR 566 FINAL EXAM .............................................................................................. Q436-551
,NR 566 MIDTERM EXAM 241 Questions
Question 1 NR 566 MIDTERM EXAM
Which non-amphetamines are FDA approved for weight loss that have lower abuse risk?
CORRECT ANSWER
Phentermine and Diethylpropion
Rationale: Phentermine and Diethylpropion are FDA-approved for weight loss and considered to have a lower abuse risk because they are anorectic
agents that are chemically distinct from amphetamines, which are a class of highly addictive stimulants. This chemical distinction, combined with their
FDA approval and lower potency compared to amphetamines, contributes to their lower abuse potential and makes them suitable alternatives for
weight loss treatment.
Question 2 NR 566 MIDTERM EXAM
How does Phentermine and Diethylpropion promote weight loss?
CORRECT ANSWER
-Promote weight loss by decreasing appetite
-They are central nervous system (CNS) stimulants that suppress appetite by increasing the availability of norepinephrine at receptors in
the brain
Rationale: Phentermine and Diethylpropion promote weight loss by influencing the brain's neurotransmitter system, specifically increasing
norepinephrine availability, which in turn suppresses appetite. This mechanism is a direct result of their classification as central nervous system (CNS)
stimulants, allowing them to effectively reduce hunger and support weight loss.
Question 3 NR 566 MIDTERM EXAM
What is the maximum recommended duration of use for non-amphetamines?
CORRECT ANSWER
3 months or less
Rationale: The key concept underlying this recommendation is that non-amphetamines, like amphetamines, can lead to physical dependence and
withdrawal symptoms, making prolonged use potentially hazardous. By limiting the duration of use to 3 months or less, the risk of dependence and
adverse effects from non-amphetamines can be minimized, aligning with the goal of promoting safe and responsible use.
Question 4 NR 566 MIDTERM EXAM
What drug schedule are Phentermine and Diethylpropion under?
CORRECT ANSWER
Schedule IV
Rationale: Phentermine and Diethylpropion are classified as Schedule IV drugs due to their potential for abuse and dependence, but their therapeutic
benefits in treating obesity outweigh the risks, allowing them to be prescribed for medical use with certain restrictions. This classification distinguishes
them from Schedule III drugs, which have a higher abuse potential, and Schedule V drugs, which have the lowest potential for abuse and dependence.
,Question 5 NR 566 MIDTERM EXAM
What labs should be monitored with Phentermine and Diethylpropion? What condition should we screen for?
CORRECT ANSWER
-baseline CMP (watch electrolytes and creatinine)
-screen for depression
Rationale: Phentermine and Diethylpropion are both sympathomimetic amines, a class of medications that can cause electrolyte imbalances and renal
impairment as side effects, necessitating the monitoring of electrolytes and creatinine levels. Additionally, these medications can have a stimulant
effect, which increases the risk of developing depression, making it essential to screen for this condition.
Question 6 NR 566 MIDTERM EXAM
Phentermine adverse effects
CORRECT ANSWER
-increase HR and BP
-dry mouth and constipation
Rationale: Phentermine is a central nervous system stimulant that works by increasing the levels of certain neurotransmitters, which can cause
increased heart rate (HR) and blood pressure (BP). The stimulant and appetite-suppressing effects of phentermine can also lead to dry mouth and
constipation as a result of decreased saliva production and reduced gut motility, respectively.
Question 7 NR 566 MIDTERM EXAM
What is role of topiramate in weight loss?
CORRECT ANSWER
Increases satiety
Rationale: Topiramate's role in weight loss is primarily attributed to its ability to increase feelings of fullness and satisfaction, thereby reducing hunger
and calorie intake, which in turn leads to weight loss. This effect is thought to be due to topiramate's action on certain neurotransmitters in the brain
that regulate appetite and food cravings, ultimately resulting in increased satiety.
Question 8 NR 566 MIDTERM EXAM
What are some Phentermine/topiramate contraindications for use?
CORRECT ANSWER
not approved in children and contraindicated with severe hepatic impairment
Rationale: This correct answer is due to the fact that Phentermine/topiramate is a controlled-release oral capsule that is not suitable for pediatric use,
and pediatric safety and efficacy have not been established. Additionally, topiramate, one of the components, is primarily metabolized by the liver,
making it contraindicated in individuals with severe hepatic impairment as they may not be able to effectively break down the medication.
, Question 9 NR 566 MIDTERM EXAM
How should we educate patient to take Phentermine/topiramate to avoid insomnia?
CORRECT ANSWER
given before 1600
Rationale: Phentermine/topiramate is a medication that combines the stimulant phentermine with the anticonvulsant topiramate, which can increase
alertness and wakefulness, increasing the risk of insomnia when taken before bed. Therefore, educating patients to take this medication in the
morning, given before 1600 hours (4 pm), helps to minimize its stimulating effects and reduce the likelihood of insomnia.
Question 10 NR 566 MIDTERM EXAM
What are some high-risk patient conditions that we should use Phentermine/topiramate with caution?
CORRECT ANSWER
hx drug abuse, glaucoma, pregnant, HTN, hyperthyroidism
Rationale: Phentermine/topiramate is a weight loss medication that affects the central nervous system, which can interact with conditions such as
glaucoma, as increased intraocular pressure could worsen glaucoma, and may exacerbate conditions like hypertension and hyperthyroidism due to its
stimulant properties. The medication's teratogenic effects also necessitate caution in pregnant individuals, while its potential for abuse and interaction
with other substances requires careful consideration in individuals with a history of substance abuse.
Question 11 NR 566 MIDTERM EXAM
Phentermine/topiramate adverse effects
CORRECT ANSWER
insomnia, nervousness, anxiety, depression, blurred vision
Rationale: Phentermine/topiramate is a medication combination used for weight loss, and its adverse effects are often related to its impact on the
central nervous system. The listed symptoms, such as insomnia, nervousness, anxiety, depression, and blurred vision, are plausible consequences of
the medication's effects on the brain, particularly given topiramate's known side effects of mood changes and visual disturbances.
Question 12 NR 566 MIDTERM EXAM
Which of the following would be a contraindication to prescribing phentermine/topiramate? Select all that apply.
CORRECT ANSWER
A) Glaucoma
B) Hypothyroidism
C) Hypertension
D) Hyperthyroidism
E) Vitamin D Deficiency
F) A, B, E
ANSWER: A,C,D
Rationale: Phentermine/topiramate is a combination medication used for weight loss, but it can increase eye pressure, worsen glaucoma, and interact
with thyroid conditions, making glaucoma, hypertension, and hyperthyroidism contraindications. The medication can also exacerbate the eye pressure
issue associated with glaucoma and the potential cardiovascular effects may be a concern for individuals with hypertension, and its effects on the
thyroid gland can be an issue for those with hyperthyroidism.
